yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q27851656-0048DE4E-B1B9-4A77-B39E-D74B51FD5641
Q27851656-0048DE4E-B1B9-4A77-B39E-D74B51FD5641
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851656-0048DE4E-B1B9-4A77-B39E-D74B51FD5641
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.
P50
Q27851656-0048DE4E-B1B9-4A77-B39E-D74B51FD5641
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851656-0048DE4E-B1B9-4A77-B39E-D74B51FD5641
rank
NormalRank
type
BestRank
Statement
P1545
4
http://www.w3.org/2001/XMLSchema#string
P1932
Keith T Flaherty
http://www.w3.org/2001/XMLSchema#string
P50
Keith Flaherty